- Report
- February 2026
- 250 Pages
Global
From €4076EUR$4,490USD£3,511GBP
- Report
- February 2026
- 250 Pages
Global
From €4076EUR$4,490USD£3,511GBP
- Report
- February 2026
- 250 Pages
Global
From €4076EUR$4,490USD£3,511GBP
- Report
- February 2026
- 250 Pages
Global
From €4076EUR$4,490USD£3,511GBP
- Report
- February 2026
- 250 Pages
Global
From €4076EUR$4,490USD£3,511GBP
- Report
- February 2026
- 250 Pages
Global
From €4076EUR$4,490USD£3,511GBP
- Report
- June 2026
- 390 Pages
Global
From €5310EUR$5,850USD£4,575GBP
- Report
- June 2026
- 173 Pages
Global
From €5310EUR$5,850USD£4,575GBP
- Report
- June 2026
- 312 Pages
Global
From €5310EUR$5,850USD£4,575GBP
- Report
- April 2026
- 180 Pages
Global
From €4312EUR$4,750USD£3,714GBP
- Report
- July 2025
- 350 Pages
Global
From €4492EUR$4,949USD£3,870GBP
- Report
- April 2026
- 160 Pages
Global
From €3767EUR$4,150USD£3,245GBP
- Report
- October 2025
- 160 Pages
Global
From €3586EUR$3,950USD£3,089GBP
- Report
- April 2026
- 128 Pages
Global
From €3500EUR$4,130USD£3,121GBP
- Report
- February 2026
- 127 Pages
Global
From €3500EUR$4,130USD£3,121GBP
- Report
- December 2025
- 52 Pages
Global
From €6808EUR$7,500USD£5,865GBP
- Report
- December 2025
Global
From €6808EUR$7,500USD£5,865GBP
- Report
- September 2025
- 126 Pages
Europe
From €5442EUR$5,995USD£4,688GBP
- Report
- September 2025
- 100 Pages
North America
From €5442EUR$5,995USD£4,688GBP
- Report
- September 2025
- 127 Pages
Asia Pacific
From €5442EUR$5,995USD£4,688GBP

Hemostasis is a process that helps to stop bleeding and is a part of the larger coagulation and hemostasis testing market. This market includes products and services used to diagnose and monitor bleeding and clotting disorders. Tests used in this market include prothrombin time (PT), activated partial thromboplastin time (aPTT), thrombin time (TT), fibrinogen, and platelet aggregation. These tests are used to diagnose and monitor conditions such as hemophilia, thrombocytopenia, and von Willebrand disease.
The coagulation and hemostasis testing market is driven by the increasing prevalence of bleeding and clotting disorders, the growing demand for point-of-care testing, and the development of new technologies. Companies in this market include Siemens Healthineers, Roche Diagnostics, Abbott Laboratories, Sysmex Corporation, and Alere Inc. Show Less Read more